Abbott abbott.com


Public list: BIO 2016 (619) Pharma Startups (6570)

Abbott (NYSE: ABT) is a global healthcare company with a portfolio of science-based offerings in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals.

Abbott (NYSE: ABT) is a global healthcare company with a portfolio of science-based offerings in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals.

Company (IPO / Went public)

Phone: +1 224 667 6100

Fax:

100 Abbott Park Road

Abbott Park, 60064
Illinois, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Abbott $0M Mar 21, 2020
See all 10 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Abbott Jobs

jobs by Indeed job
						search
There is no Investors data available for this company. Please select another tab.
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Alexza Pharmaceuticals

Mountain View, California, United States
AcquiredAlexza is developing drugs for acute and intermittent medical conditions. Their Staccato system aerosolizes without thermal degradation, enabling convenient delivery and rapid therapeutic onset of many small molecule drugs. The company has product candidates in clinical trials for migraine headaches, acute panic attacks, acute agitation in schizophrenia and acute pain.Login to see details

Agios Pharmaceuticals

Cambridge, Massachusetts, United States
IPO / Went publicAgios Pharmaceuticals is a biopharmaceutical company dedicated to the discovery and development of therapeutics in the field of cancer metabolism. To support and drive these efforts, Agios has built a platform integrating cancer biology, metabolomics, biochemistry and informatics to enable target and biomarker identification. Agios' capabilities to interrogate differential cellular metabolism of diseased cells relative to normal cells may also be applicable to other therapeutics areas including ...Show allLogin to see details
See all 10 competitors